Highlights
NASDAQ: CGIX       Cancer Genetics Inc
Last Price Today's Change   Day's Range   Trading Volume
3.18   +0.02 (0.63%)  3.05 - 3.28  172,759

Overview

 
Avg Volume (4 weeks):580,327
4 Weeks Range:2.56 - 4.10
4 Weeks Price Volatility (%):
40.26%
52 Weeks Range:1.92 - 10.39
52 Weeks Price Volatility (%):
14.88%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cancer Genetics Inc is in early stage of precision medicine, enabling individualized therapies in the field of oncology through diagnostic products and services and molecular markers. The company develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient by providing genomic information to better diagnose, monitor and inform cancer treatment. It also enables biotech and pharmaceutical companies engaged in oncology trials to better select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. Cancer Genetics derive most of its revenue from United States of America.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2573  3852  201  3255 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 0.714+0.023 
 BNGO 8.43+1.48 
 CCIV 18.36+1.00 
 LK 1.38+1.38 
 CTRM 0.336-0.024 
 AMC 2.33+0.15 
 BB 9.84+0.73 
 OBSV 4.07+1.55 
 AVGR 1.47+0.36 
 NIO 56.27-4.60 

TOP ARTICLES

1. Equities Retreated on Waning Optimism State of The Markets
2. Daily Futures Trading Strategy 15 January 2021 Where Futures Lies
3. CryptoNews of the Week CryptoNews
4. Markets Mixed on Hedging State of The Markets
5. Impeachment, Stimulus And The Markets Wall Street Breakfast